GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hans Biomed Corp (XKRX:042520) » Definitions » Research & Development

Hans Biomed (XKRX:042520) Research & Development : ₩4,443 Mil (TTM As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Hans Biomed Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hans Biomed's Research & Development for the three months ended in Mar. 2025 was ₩1,119 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩4,443 Mil.


Hans Biomed Research & Development Historical Data

The historical data trend for Hans Biomed's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hans Biomed Research & Development Chart

Hans Biomed Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,511.22 7,147.93 5,657.80 5,597.40 4,627.86

Hans Biomed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,214.55 966.38 1,408.51 949.41 1,118.78

Hans Biomed Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩4,443 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hans Biomed  (XKRX:042520) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hans Biomed Research & Development Related Terms

Thank you for viewing the detailed overview of Hans Biomed's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hans Biomed Business Description

Traded in Other Exchanges
N/A
Address
No.7, Jeong-i-ro 8-gil, Songpa-gu, Seoul, KOR
Hans Biomed Corp manufactures and markets bioengineering products. The company manufactures and sells skin and bone grafts for human transplantation, medical devices, silicone products, etc.

Hans Biomed Headlines

No Headlines